Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis-Phase 3 Trial Report Vinay Singh singh23 Aug 2018 7:25 PM ISTTreatment with either certolizumab 400 mg or 200 mg every 2 weeks was associated with significant and clinically meaningful improvements in...
Baldness can now be treated with platelet-rich plasma Medha Baranwal Baranwal10 Oct 2018 8:20 PM ISTTreatment with platelet-rich plasma (PRP) in patients with androgenetic alopecia or baldness yielded promising results, according to a new study...
Psoriasis patients more prone to thyroid diseases, finds new study Medha Baranwal Baranwal13 Dec 2018 7:05 PM ISTTaiwan: Psoriasis patients are at higher risk of developing thyroid diseases including hypothyroidism, thyroiditis, hyperthyroidism, and specific...
People who smoke have increased risk of psoriasis Medha Baranwal Baranwal1 Jan 2019 7:25 PM ISTTaipei, Taiwan: People who smoke are at increased risk of developing psoriasis, the risk is further augmented for individuals who smoked >25...
Two New Psoriasis Guidelines address Treatment and Comorbidities Hina Zahid15 Feb 2019 7:10 PM ISTAmerican Academy of Dermatology and the National Psoriasis Foundation have released two new guidelines outlining best practices for managing the...
Manage comorbidities, use biologics, emphasize new Psoriasis Guidelines Hina Zahid5 March 2019 7:28 PM ISTManage comorbidities, use biologics, emphasize two new new evidence-based Psoriasis Guidelines.The American Academy of Dermatology (AAD) and the...
Compared to antibiotics, Spironolactone may be safe first line treatment for Acne Medha Baranwal Baranwal7 April 2019 7:30 PM ISTUSA: Spironolactone can be a potential alternative to oral antibiotics for the treatment of women with acne -- is the bottom line of a recent study....
Combo helps achieve faster skin clearance in rosacea patients Medha Baranwal Baranwal1 July 2019 7:20 PM ISTNew Delhi: Addition of 40 mg doxycycline modified-release capsules (DMR) to daily ivermectin 1% cream produces faster responses and increases...
For treatment of chronic spontaneous urticaria methotrexate not superior to placebo Medha Baranwal Baranwal26 Aug 2019 7:15 PM ISTFrance: Methotrexate is not superior to placebo+H1-antihistamines for the treatment of chronic spontaneous urticaria, so methotrexate may be used as...
Patients of Psoriasis at increased risk of mortality, finds recent study Medha Baranwal Baranwal9 Sept 2019 7:05 PM ISTUSA: People with psoriasis are at increased risk of mortality, finds a recent study published in the Journal of the American Academy of Dermatology....
In female pattern hair loss low-dose oral minoxidil as effective as topical minoxidil: JAAD Dr. Kamal Kant Kohli Kohli19 Sept 2019 7:30 PM ISTTopical minoxidil (TM) is the only FDA-approved drug for the treatment of female pattern hair loss (FPHL). Premature discontinuation of treatment...
Atopic dermatitis patients are at increased long-term risk for AF Medha Baranwal Baranwal18 Sept 2019 7:15 PM ISTDelhi: Patients with moderate to severe atopic dermatitis have a 20% increased long-term risk of atrial fibrillation, according to a 35 year-long...
